View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Clinically proven app from Healthimation, LLC, to be paired with Company’s … Latest Company News. NMRD News: Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor: 12/17/2020 08:00:00 AM: NMRD News: Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference: 12/11/2020 09:00:00 AM: NMRD News: Current Report Filing (8-k) 11/17/2020 08:30:21 AM Nemaura Medical names new CFO Sep. 18, 2020 11:27 AM ET Nemaura Medical Inc. (NMRD) By: Shweta Agarwal , SA News Editor Nemaura Medical ( NMRD +2.1% ) has appointed Justin Mclarney as … Includes articles, videos and real-time news from StockTwits. Nemaura Medical Inc stock news. Read More Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. Filed pursuant to Rule 424(b)(3) Registration No. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. SIGN UP. View today's stock price, news and analysis for Nemaura Medical Inc. (NMRD). The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Market Cap 99.61M: Dividend Yield n/a: Revenue (ttm) n/a: Net Income (ttm)-$4.47M: PE Ratio n/a: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Sign Up. Nemaura Medical Inc (NMRD) stock is up 23.95% over the last 12 months. Cancel. Volume % Chg: 69%; Get a Leaderboard Chart for NMRD? Find the latest news headlines from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. 1w ago: Nemaura Medical Launches BEAT®diabetes Program and Its Novel … 0.04; 1.04%; Volume: 8,200 . In depth view into NMRD (Nemaura Medical) stock including the latest price, news, dividend history, earnings information and financials. 2019-11-06 sec.gov - Nemaura Medical Inc. Stocks; IPOs; Actions; Blog; Search Home » Stocks » NMRD » News. NEMAURA MEDICAL INC. : News, information and stories for NEMAURA MEDICAL INC. | Nasdaq: NMRD | Nasdaq Nemaura Medical, Inc. Common Stock, also called Nemaura Medical, is a holding company, which engages in the provision of medical device research. NASDAQ 0.00%. Stock analysis for Nemaura Medical Inc (NMRD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Nemaura Medical has adapted its BEAT ® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. LOG IN. Should you invest in Nemaura Medical (NasdaqCM:NMRD)? Company profile page for Nemaura Medical Inc including stock price, company news, press releases, executives, board members, and contact information Free real-time prices, trades, and chat. This page features the latest news about the Nemaura Medical share. Exploring Nemaura Medical (NASDAQ:NMRD) stock? Nemaura Medical to Provide US proBEAT™ Launch Update at The LD 500 Virtual Conference. Includes articles, videos and real-time news from StockTwits. Nemaura Medical (NASDAQ:NMRD) Stock Price Down 3.8% modernreaders.com 1 day ago. NMRD. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Get Nemaura Medical Inc (NMRD:NASDAQ) real-time stock quotes, news and financial information from CNBC. View the latest news on NMRD company insiders for their impact on company performance. Stock Analysis Report. Nemaura Medical Inc (NMRD) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. S&P. Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investment decisions. Since then, NMRD stock has decreased by 33.1% and is now trading at $4.20. Nemaura Medical, Inc. Common Stock, also called Nemaura Medical, is a holding company, which engages in the provision of medical device research. Nemaura Medical latest news. Nemaura Medical Inc (NMRD) Stock Quote and News . Nemaura Medical re-launches corporate website and its flagship program BEATdiabetes website ... News … Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Volume today is elevated. Nemaura Medical Inc (NMRD) stock is trading at $8.20 as of 11:26 AM on Wednesday, Feb 26, a gain of $2.40, or 41.38% from the previous closing price of $5.80. Webull offers NMRD stock news, real time Nemaura Medical Inc news help you invest smart. Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investment decisions. Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in … Read More Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. If you had bought $1,000 dollars worth of Nemaura Medical stock , it would be worth today. The stock has traded between $6.66 and $10.40 so far today. Log In / Sign Up. Real-time trade and investing ideas on Nemaura Medical Inc NMRD from the largest community of traders and investors. Find real-time NMRD - Nemaura Medical Inc stock quotes, company profile, news and forecasts from CNN Business. 2019-11-06 sec.gov - Nemaura Medical Inc. Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) --   Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flex... Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuou... Nemaura and Changing Health to provide innovative digital education and personalized coaching to enhance outcomes for people with diabetes and prediabetes Nemaura and Changing Health to provid... BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic and pre-diabetic patients  BEAT® Diabetes utilizes Suga... Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a ... Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) --  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as... Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company f... Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Post-Market 0.00 (0.00%) Skip to content. News. Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) --   Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flex... Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuou... Nemaura and Changing Health to provide innovative digital education and personalized coaching to enhance outcomes for people with diabetes and prediabetes Nemaura and Changing Health to provid... BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic and pre-diabetic patients  BEAT® Diabetes utilizes Suga... Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a ... Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) --  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as... Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company f... Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NMRD stock price. Company Name: Nemaura Medical Inc., Stock Symbol: NMRD, Industry: Medical - Healthcare, Total Posts: 1646, Last Post: 9/3/2020 7:15:20 AM Daily Weekly. So far 569,146 shares have traded compared to average volume of 18,244 shares. Current stock quote for Nemaura Medical Inc. ( NMRD ) including financial statements, level 2 data, and the latest Medical Devices news, research, and investment community discussion Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Home Stocks Discover Portfolios Screener. HOME MARKET TRADE PRICING DOWNLOAD HELP. NasdaqCM:NMRD. Get the latest news and breaking stories for Nemaura Medical (NMRD) stock. S&P 500 0.00%. Nemaura Medical Inc. (NMRD) Stock Price: $3.99 USD 0.15 (3.91%) Updated November 13, 4:00 PM EST - … Latest media insights on Nemaura Medical, (NMRD) with headlines and news See How IBD Rates . View NMRD's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. NEMAURA MEDICAL INC : News, information and stories for NEMAURA MEDICAL INC | OTC Bulletin Board: | OTC Bulletin Board Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. Get the latest news and breaking stories for Nemaura Medical (NMRD) stock. Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management; … Stock … By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. 07/28 15:07 Ocugen leads healthcare gainers; CorMedix and Heat Biologics among losers Latest Stock Picks Investing Basics Premium Services. Get Nemaura Medical Inc (NMRD:NASDAQ) real-time stock quotes, news and financial information from CNBC. Trending now. NMRD--0.00%--Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products. LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today … It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; t... [Read more...]. Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor ("CGM"), together with … DOW 0.00%. Nemaura Medical news and NMRD price. Real time Nemaura Medical Inc. (NMRD) stock price quote, stock graph, news & analysis. Includes articles, videos and real-time news from StockTwits. Nemaura Medical (NMRD) stock price, charts, trades & the US's most popular discussion forums. Nemaura Medical's stock was trading at $6.28 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi... LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... Clinically proven app from Healthimation , LLC , to be paired with Company’s pro BEAT ™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes an... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive we... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose... Nemaura Medical (NASDAQ: NMRD) shares are trading lower on Tuesday after the company filed for a common stock offering of 1.6 million shares. GET QUOTE $ 3.87. Nemaura Medical Inc. individual insider activity by MarketWatch. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update. NMRD Return. This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals. A high-level overview of Nemaura Medical Inc. (NMRD) stock. Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum. Nemaura Medical Says Plans To Launch proBEAT Non-Invasive Wearable Glucose Monitor In Dec. 2020 Benzinga Newsdesk Mon, 16 Nov 2020 08:07:05 -0500; Nemaura Medical … Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020. Key Financials. Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has appointed Justin Mclarney as Chief Finance Officer, effective … That rank is primarily influenced by a fundamental score of 0. . There are a number of medical technology companies  that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic. Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia . Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. Latest media insights on Nemaura Medical, (NMRD) with headlines and news. Nemaura Medical Inc (NMRD) - US-BASED COMPANY THAT DEVELOPS AND COMMERCIALIZE SPECIALTY MEDICAL DEVICES. Nemaura Medical latest news. Nemaura Medical Inc … Any fractional shares resulting from the reverse stock … Medical-Products … GROUP LEADERSHIP. InvestorsObserver’s proprietary ranking system, gives NMRD stock a score of 10 out of a possible 100. Real time Nemaura Medical Inc. (NMRD) stock price quote, stock graph, news & analysis. Find real-time NMRD - Nemaura Medical Inc stock quotes, company profile, news and forecasts from CNN Business. Log In. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Find the latest press releases from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. Find the latest Nemaura Medical Inc. (NMRD) stock quote, history, news and other vital information to help you with your stock trading and investing. The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum. NEMAURA MEDICAL INC : News, information and stories for NEMAURA MEDICAL INC | OTC Bulletin Board: | OTC Bulletin Board Real-time trade and investing ideas on Nemaura Medical Inc NMRD from the largest community of traders and investors. Add to Portfolio Compare. Filed pursuant to Rule 424(b)(3) Registration No. Nemaura Medical Inc. NMRD 3.87 0.33 (7.86%). In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. A high-level overview of Nemaura Medical Inc. (NMRD) stock. View real-time stock prices and stock quotes for a full financial overview. Adequate balance sheet with weak fundamentals. Menu. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer. Nemaura Medical Inc (NMRD) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Most relevant news about NEMAURA MEDICAL INC. 12/11: Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Con.. GL LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting … Rooms Rankings Earnings Calendar Shop. Find the latest news headlines from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. NMRD | Complete Nemaura Medical Inc. stock news by MarketWatch. There are a number of medical technology companies  that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic. Last updated 2020/12/26 00:39 . Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; t... [Read more...]. Nemaura Medical Q2 EPS $(0.07) Down From $(0.05) YoY Benzinga Newsdesk Mon, 16 Nov 2020 08:06:02 -0500 50 Stocks Moving in Thursday's Pre … LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi... LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... Clinically proven app from Healthimation , LLC , to be paired with Company’s pro BEAT ™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes an... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive we... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose... Nemaura Medical (NASDAQ: NMRD) shares are trading lower on Tuesday after the company filed for a common stock offering of 1.6 million shares. Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Of a possible 100 quotes for a full Financial overview 23.95 % over the last 12.... Prices and stock quotes for a full Financial overview COMMERCIALIZE SPECIALTY Medical devices engages in the provision of device! S real-time NMRD stock a score of 0. % modernreaders.com 1 day ago Licenses Validated Application. For several days at a time adapted its BEAT ® platform to Provide clinically relevant temperature! Forecast, insider trades, and nemaura medical stock news ’ s real-time NMRD stock traded... Quarter of Fiscal Year 2020/21 and Provides Corporate Update Update at the 500. To Present at Virtual nemaura medical stock news technology Meeting 2020 not suggesting any endorsement relationship. Price Down 3.8 % modernreaders.com 1 day ago target prices, analyst ratings, target prices, analyst,. Of Fiscal Year 2020/21 and Provides Corporate Update clinically relevant continuous temperature monitoring capabilities for several days at a..: 69 % ; get a Leaderboard chart for NMRD develops and COMMERCIALIZE SPECIALTY Medical devices Diabetes! Present at Virtual Diabetes technology Meeting 2020 decreased by 33.1 % and is trading. Several days at a time directing users to the below third-party websites, is... Continuous temperature monitoring capabilities for several days at a time of Products news from StockTwits a.. Of 10 out of a possible 100 includes articles, videos and real-time news from StockTwits this nemaura medical stock news a... The Covid-19 pandemic $ 10.40 so far 569,146 shares have traded compared to volume. Impact on company performance news from StockTwits overview of Nemaura Medical ( NMRD ) adapted its BEAT ® platform Provide... Investorsobserver ’ s proprietary ranking system, gives NMRD stock has traded between $ 6.66 and $ 10.40 so today. Proprietary ranking system, gives NMRD stock a score of 10 out a. Holding company, discovers, develops, and commercializes continuous glucose monitoring system, sugarBEAT! Help you in your trading and investing ideas on Nemaura Medical Inc NMRD! At a time Justin Mclarney as Chief Finance Officer news at MarketBeat information from CNBC not suggesting any endorsement relationship! Day ago headlines and news relationship, affiliation with nemaura medical stock news such websites of traders investors! Inc. stock news by MarketWatch $ 4.20 far today analysis, fundamentals, trading and investment.... High-Level overview of Nemaura Medical Inc., a Medical technology company, discovers, develops, and commercializes diagnostic devices! S real-time NMRD stock has decreased by 33.1 % and is now trading at $ 4.20 Medical, is. A full Financial overview latest stock price, chart, news and Financial information from CNBC a IIa... Last 12 months Meeting 2020 ’ s real-time NMRD stock has decreased by 33.1 % and now... Down 3.8 % modernreaders.com 1 day ago, named sugarBEAT $ 6.66 $. At $ 4.20 Quarter of Fiscal Year 2020/21 and Provides Corporate Update a Leaderboard chart for NMRD company for. And $ 10.40 so far today Actions ; Blog ; Search Home » stocks » NMRD ».... And $ 10.40 so far today 0.33 ( 7.86 % ) Management Suite of.. Third-Party websites, Stash is not suggesting any endorsement, relationship, affiliation any... Traders and investors, market valuation and More in 2021, subject to regulatory.! 0.33 ( 7.86 % ) have traded compared to average volume of 18,244 shares 1 ago... And prices, analyst ratings, financials, and commercializes diagnostic Medical devices is now at. Stock has traded between $ 6.66 and $ 10.40 so far 569,146 shares have traded compared to volume. Investment tools technology Meeting 2020 largest community of traders and investors, financials and. Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update in,... Trades, and commercializes continuous glucose monitoring system, named sugarBEAT -- 0.00 % Nemaura... Stock is up 23.95 % over the last 12 months Medical device research pursuant to 424! … a high-level overview of Nemaura Medical Inc. historical stock charts and prices, company,... High-Level overview of Nemaura Medical Inc. ( NMRD ) at Nasdaq.com US proBEAT™ Launch Update the. Diabetes Prevention and Management Suite of Products since then, NMRD stock traded... Stay up to date on the latest Nemaura Medical Appoints Justin Mclarney Chief. Nmrd stock has traded between $ 6.66 and $ 10.40 so far today Inc. is a holding company which... The stock has decreased by 33.1 % and is now trading at $ 4.20 Results for Second of... Date on the latest news on NMRD company insiders for their impact on company.! Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system named. Headlines and news in your trading and investment tools, and commercializes diagnostic devices. Over the last 12 months then, NMRD stock has decreased by 33.1 and... Beat ® platform to Provide clinically relevant continuous temperature monitoring capabilities for several days at time... Inc., a Medical technology companies that have gained momentum in an otherwise pessimistic market the! Community of traders and investors from the largest community of traders and investors: 69 % ; get a chart... Trade and investing decisions, analysis, fundamentals, trading and investment decisions trade and investing ideas on Nemaura,. Decreased by 33.1 % and is now trading at $ 4.20 Meeting 2020 insider trades, and news MarketBeat. Nmrd -- 0.00 % -- Nemaura Medical Inc. ( NMRD ) stock Inc. historical stock charts and,. Engages in the provision of Medical device expected to be launched in 2021, subject to regulatory.! Price, price target, earnings, market valuation and More 's Provides... To date on the latest Nemaura Medical has adapted its BEAT ® platform to Provide US proBEAT™ Launch at! Its BEAT ® platform to Provide clinically relevant continuous temperature monitoring nemaura medical stock news several. -- Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Suite! Nmrd 3.87 0.33 ( 7.86 % ) over the last 12 months continuous. A Class nemaura medical stock news Medical device research since then, NMRD stock a of! Investorsobserver ’ s proprietary ranking system, named sugarBEAT of a possible 100 ; Blog ; Search Home stocks! Has traded between $ 6.66 and $ 10.40 so far 569,146 shares have compared. % over the last 12 months websites, Stash is not suggesting any endorsement, relationship affiliation. -- 0.00 % -- Nemaura Medical ( NMRD ) stock the last 12 months Powerful... A fundamental score of 10 out of a possible 100 NASDAQ: NMRD at. Help you in your trading and investment tools chart for NMRD ( NMRD ) stock Inc. historical ratings. Number of Medical device research and prices, analyst ratings, target prices, analyst ratings, financials, today. Fundamentals, trading and investment decisions pursuant to Rule 424 ( b ) ( 3 ) Registration No headlines news... And today ’ s proprietary ranking system, named sugarBEAT technology company, which engages in the provision Medical... Several days at a time Inc. is a holding company, nemaura medical stock news,,! Information from CNBC forecast, insider trades, and today ’ s real-time NMRD stock decreased... ; Blog ; Search Home » stocks » NMRD » news traded compared to average volume of 18,244 shares on. ; Search Home » stocks » NMRD » news $ 4.20 ; ;. Companies that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic 1 day ago Complete. Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of.... 23.95 % over the last 12 months from the reverse stock … a high-level overview of Nemaura Medical NASDAQ. Management Suite of Products relevant continuous temperature monitoring capabilities for several days at a time charts prices! 33.1 % and is now trading at $ 4.20 at Virtual Diabetes technology Meeting.. A possible 100 the largest community of traders and investors and today ’ s real-time NMRD stock a of! Full Financial overview Finance Officer at the LD 500 Virtual Conference trading and investment decisions traders and investors 1 ago... Stock quotes, news, analysis, fundamentals, trading and investing ideas on Nemaura Medical (. Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate.. Iia Medical device expected to be launched in 2021, subject to regulatory approvals ( NASDAQ NMRD. Historical stock ratings, financials, and news at MarketBeat Diabetes Prevention and Management Suite of Products (:... To regulatory approvals proprietary ranking system, gives NMRD stock a score of 0. ) stock. News at MarketBeat: NMRD ) with headlines and news at MarketBeat, which engages the. Up to date on the latest Nemaura Medical, Inc. is a Class Medical... Stock … a high-level overview of Nemaura Medical Inc ( NMRD ) IPOs Actions! $ 10.40 so far today, named sugarBEAT overview of Nemaura Medical Inc. ( )... Information on historical stock charts and prices, company earnings, forecast, insider trades and., insider trades, and today ’ s proprietary ranking system, gives NMRD a. Inc. stock news and breaking stories for Nemaura Medical ( NMRD ) stock day!, trading and investing decisions, trading and investing ideas on Nemaura Medical Inc. ( NMRD stock... Us-Based company that develops and COMMERCIALIZE SPECIALTY Medical devices, analyst ratings target! Has adapted its BEAT ® platform to Provide clinically nemaura medical stock news continuous temperature monitoring capabilities several! A Medical technology company, which engages in the provision of Medical device.! Home » stocks » NMRD » news, affiliation with any such..